Interaction of Severe Acute Respiratory Syndrome Coronavirus 2 and Diabetes
중증급성호흡기증후군 코로나바이러스 2와 당뇨병의 상호작용
Review
[키워드] ACE2
ACE2 protein
acute respiratory syndrome
acute respiratory syndrome coronavirus
aggravate
angiotensin
Angiotensin-converting enzyme
angiotensin-converting enzyme 2
animal models
Anti-inflammatory
binding
cause
cells
coronavirus
coronavirus 2
COVID – 19
damage
diabete
diabetes
diabetes - quality of life
Diabetic
diabetic patient
diabetic patients
dipeptidyl peptidase
DPP4
drug
Effect
Epidemic
expression
focus
furin
glucagon
glucagon-like peptide
glucagon-like peptide 1
identify
immune disorder
immunocellular response
influence
influences
inhibitor
insulin
insulin resistance
involved
islets
lung
lung dysfunction
mechanism
metformin
mTOR
mTOR signaling
OAD
OADs
organs
outcome
pancreatic
Patient
peptidase
peptide
PPARγ
Rapamycin
receptor
respiratory
risk
SARS-CoV-2
SARS-CoV-2 (2019-nCoV)
SARS-COV-2 infection
SARS-CoV-2 infections
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus 2
shown
signaling pathway
Spread
suppression
Treatment
Trigger
type 2 diabete
Type 2 diabetes mellitus
underlying disease
underlying diseases
[DOI] 10.3389/fendo.2021.731974 PMC 바로가기 [Article Type] Review
[DOI] 10.3389/fendo.2021.731974 PMC 바로가기 [Article Type] Review